FDA turmoil deepens as top drug chief departs claiming she was fired
Summary
Several top leaders at the US Food and Drug Administration (FDA) have left or been fired, including the acting heads of drug and vaccine regulation. The agency currently has no permanent commissioner or deputy commissioner, and a new acting commissioner has been named.Key Facts
- Tracy Beth Høeg, acting head of the Center for Drug Evaluation and Research, said she was fired after six months in the role.
- Katherine Szarama, acting head of the Center for Biologics Evaluation and Research, who had just started, is also reportedly leaving.
- Jim Traficant, FDA chief of staff, was removed from his position.
- Marty Makary, FDA commissioner, resigned earlier in the week.
- The agency now lacks permanent leaders in its top positions.
- Kyle Diamantas, formerly the top food regulator, is the new acting FDA commissioner.
- Michael Davis will act as director of the drug evaluation center.
- Karim Mikhail, previously CEO of a pharmaceutical company, will temporarily lead the biologics center.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.